Healthcare Industry News: joint replacement
News Release - July 9, 2013
Biomet Announces Launch of ePAK(TM) Single-Use Delivery SystemWARSAW, Ind.--(Healthcare Sales & Marketing Network)--Biomet, Inc., a global leader in the manufacture of orthopaedic and biotechnology products, today announced the official release of the ePAK™ Single-Use Delivery System, the latest in innovative technology for internal fracture fixation. The system is a pre-sterilized, single-use procedure pack designed to add value by addressing the productivity needs of the operating room in one complete package that is designed to help to save time, reduce cost, improve efficiency, and ultimately increase productivity.
The ePAK™ Single-Use Delivery System addresses distal radius fractures and features the DVR® Crosslock implant and instrumentation. With over 10 years of clinical heritage in treating distal radius fractures using the volar approach, the DVR® plate and instrumentation continue to refine fracture fixation.
Wil Boren, President of Biomet Sports Medicine, Extremities and Trauma, commented, “We are pleased to announce the release of this revolutionary advancement in orthopaedic delivery systems. The ePAK™ Single-Use System is an all-around solution, and we are excited to be the first orthopaedic company to release a device in this category that addresses the needs of the orthopaedic surgeon, patient, and the hospital system. We are confident that both the ePAK™ System and the DVR® Crosslock will be important additions to our already successful trauma portfolio.”
Biomet, Inc. (www.biomet.com) and its subsidiaries design, manufacture and market products used primarily by musculoskeletal medical specialists in both surgical and non-surgical therapy. Biomet’s product portfolio encompasses large joint reconstructive products, including orthopedic joint replacement devices, and bone cements and accessories; sports medicine, extremities and trauma products, including internal and external orthopedic fixation devices; spine and bone healing products, including spine hardware, spinal stimulation devices, and orthobiologics, as well as electrical bone growth stimulators; dental reconstructive products; and other products, including microfixation products and autologous therapies. Headquartered in Warsaw, Indiana, Biomet and its subsidiaries currently distribute products in approximately 90 countries.
Source: Biomet, Inc
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.